ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2019 and Provide a Corporate Strategic Update

Conference Call to be Held on March 24, 2020

RANCHO CORDOVA, Calif., March 18, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the year ended December 31, 2019 and provide a corporate strategic update on Tuesday, March 24, 2020 after the close of trading.  A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A replay of the call will be available until April 9 and can be accessed by dialing 1-877-344-7529 (domestic), 1-412-317-0088 (international) or 1-855-669-9658 (Canada) and referencing access code 10139041. The webcast will be available for three months.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc., develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.ThermoGenesis.com.


Company Contact:
Wendy Samford

Investor Contact:
Paula Schwartz, Rx Communications


Leave a Reply

Your email address will not be published. Required fields are marked *

© 2020 ThermoGenesis Corp.
How may we help?